CLINICAL_TRIALS
trial_result
· 2016-01-18
Clinical Trial Update: Urticaria Facticia Treatment With Omalizumab (UFO) [Phase 2]
Summary
Phase 2 trial update of omalizumab for urticaria symptoms (symptomatic dermographism) completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Charite University, Berlin, Germany | Conditions: Symptomatic Dermographism | Phase 2 | Status: COMPLETED | Results posted: 2016-01-18